The McLean Screening Instrument-BPD is a 10-item, yes/no, self-report patient screening scale. It is used with an undiagnosed population to identify people who need further evaluation for BPD. The scale demonstrates strong sensitivity (the degree to which it correctly identifies patients who do have the disorder), as well as strong specificity (the degree to which it correctly identifies patients who do not have the disorder).

The Zanarini Rating Scale for BPD is a nine-item, validated, clinician-based diagnostic interview. It assesses the severity of DSM-IV-based Borderline Personality Disorder symptoms. This scale also measures meaningful changes in symptoms over time. The 0-4 points rating ranges from No Symptoms (0) to Severe Symptoms (4) for the following categories: Affective: Inappropriate anger / frequent angry acts; chronic feelings of emptiness; mood instability Cognitive: Stress-related paranoia / dissociation; severe identity disturbance based on false personal beliefs Impulsive: Self-mutilation and/or suicidal efforts; two other forms of impulsivity Interpersonal: Unstable interpersonal relationships; frantic efforts to avoid abandonment

In the Fullness of Time debunks the common myth that BPD is incurable, drawing on the findings of the NIMH-funded study, the McLean Study of Adult Development, which has found that BPD has the best symptomatic outcome of all major mental illnesses.

This forward-thinking volume grapples with critical questions surrounding the mechanisms underlying mental disorders and the systems used for classifying them. Edited and written by leading international authorities, many of whom are actively involved with the development of DSM-V and ICD-11, the book integrates biological and psychosocial perspectives. It provides balanced analyses of such issues as the role of social context and culture in psychopathology and the pros and cons of categorical versus dimensional approaches to diagnosis. Cutting-edge diagnostic instruments and research methods are reviewed. Throughout, contributors highlight the implications of current theoretical and empirical advances for understanding real-world clinical problems and developing more effective treatments.

It has been almost twenty years since DSM-III created a major shift in psychi atric classification procedures and in diagnostic and treatment practice by introducing the multi-axial system and, for our patients specifically, the Axis II: Personality Disorders. Researchers and clinicians were forced to focus on many issues related to the field of personality and its disorders. This meant an immense impetus for research, both empirical and theoretical. Many recent developments are described in this book, as reviews or as original articles. This book also covers developments in Europe as well as in North America. Important questions still remain unanswered, such as: What is the relationship between the different clusters: A, B, & C? Are we talking about dimensions, categories, or typologies? What can be done for patients who have more than one personality disorder? Is a pro typical approach required? Consequently, is a multiconceptual approach in treatment and research required? The authors contribute to this discus sion and provide guidelines for further thinking in research and treatment planning. For clinicians, it is of major importance to know whether the disorder can be influ enced by treatment, and whether permanent change is really possible. A very impor tant question is whether a person indeed has a personality disorder, and how this diagnosis affects clinical practice.

Borderline Personality Disorder in Adolescents is a comprehensive guide to BPD, offering an overview of the disorder, its treatment options, and advice on how to live with it day-to-day.

This book is a complete guide to using the evidence-based Good Psychiatric Management (GPM) approach for the treatment of BPD. The book demystifies the disorder, supplying treatment guidelines, case studies, and online video demonstrations of core techniques needed to deliver effective short-term, intermittent, and non-intensive therapeutic care.